Mobile Photon Counting Detector CT for Neuroimaging in ICU
Author Information
Author(s): Park Su-Jin, Han Kwanhee, Park Junyoung, Min Jonghwan, Wu Dufan, Kim Doil, Kang Kyutae, Lee Duhgoon, Gupta Rajiv, Jung Jinwook
Primary Institution: Samsung Electronics Co., Ltd
Hypothesis
Can the MD Plus algorithm on mobile PCD-CT accurately differentiate between contrast agent and hemorrhage in hyperdense lesions?
Conclusion
The MD Plus algorithm with mobile PCD-CT can effectively distinguish between hemorrhage and iodine contrast agent in neuro-patients.
Supporting Evidence
- The MD Plus algorithm was validated using a multi-energy phantom.
- Clinical applications demonstrated the ability to differentiate between iodine contrast and hemorrhage.
- The mobile PCD-CT allows for bedside imaging, reducing risks associated with patient transport.
Takeaway
This study shows that a new type of CT scan can help doctors tell the difference between bleeding in the brain and a special dye used in scans, which is really important for treating patients quickly.
Methodology
The study evaluated the MD Plus algorithm using a mobile PCD-CT scanner and a certified multi-energy phantom to validate its performance.
Limitations
The study had a relatively low number of patients and used different imaging techniques for follow-up.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website